| dc.contributor.author | Dinnes, Jacqueline et al. | |
| dc.date.accessioned | 2020-10-19T20:20:21Z | |
| dc.date.available | 2020-10-19T20:20:21Z | |
| dc.date.issued | 2020-08-26 | |
| dc.identifier.uri | https://doi.org/10.1002/14651858.CD013705 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12663/2366 | |
| dc.description.abstract | Background: Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and the resulting COVID‐19 pandemic present important diagnostic challenges. Several diagnostic strategies are available to identify or rule out current infection, identify people in need of care escalation, or to test for past infection and immune response. Point‐of‐care antigen and molecular tests to detect current SARS‐CoV‐2 infection have the potential to allow earlier detection and isolation of confirmed cases compared to laboratory‐based diagnostic methods, with the aim of reducing household and community transmission. | en_US |
| dc.language | English | en_US |
| dc.subject | COVID-19 | en_US |
| dc.subject | Betacoronavirus | en_US |
| dc.subject | Antigens, Viral | en_US |
| dc.subject | Clinical Laboratory Techniques | en_US |
| dc.subject | Coronavirus Infections | en_US |
| dc.subject | False Negative Reactions | en_US |
| dc.subject | False Positive Reactions | en_US |
| dc.subject | Pandemics | en_US |
| dc.subject | Pneumonia, Viral | en_US |
| dc.subject | Point-of-Care Systems | en_US |
| dc.subject | Sensitivity and Specificity | en_US |
| dc.title | Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection | en_US |
| eihealth.country | Others | en_US |
| eihealth.category | Infection prevention and control, including health care workers protection | en_US |
| eihealth.type | Published Article | en_US |
| eihealth.maincategory | Slow Spread / Reducir la Dispersión | en_US |
| dc.relation.ispartofjournal | Cochrane Database of Systematic Reviews | en_US |
